The enzymes in the cytochrome p450 monooxygenase system (CYP) are the major
enzymes responsible for metabolizing medications. The CYP2D6 isomer is res
ponsible for metabolizing certain opioids, neuroleptics, antidepressants an
d cardiac medications. Owing to CYP2D6's low capacity and high affinity it
is easily saturated by substrate and/or inhibited, resulting in pharmacokin
etic interactions. Polymorphisms of the structural gene are common, leading
to wide inter-individual and ethnic differences in drug metabolism. Clinic
ally important drug interactions, which may be anticipated in the palliativ
e medicine population, are reviewed.